Anexigen is a developer of novel methods and compositions designed to combat existing and burgeoning antimicrobial threats. The company's platform has the potential to identify novel antibacterial agents with activity against drug-resistant bacteria of biomedical interest and enables functional screening of DNA-encoded peptide-based libraries